FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076254 [Registered on: 04/11/2024] Trial Registered Prospectively
Last Modified On: 04/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Single Arm Study 
Public Title of Study   Predicting Continuous Positive Airway Pressure Success Using Respiratory Rate Oxygenation Index (ROX) in Neonates with Respiratory Distress Syndrome 
Scientific Title of Study   Role of ROX index in predicting CPAP effectiveness in Neonates with Respiratory Distress Syndrome 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  GURDEEP SINGH DHOORIA 
Designation  Professor 
Affiliation  DAYANAND MEDICAL COLLEGE AND HOSPITAL, LUDHIANA 
Address  Dept of Pediatrics, Ward number 209, second floor Dayanand Medical College and Hospital, Ludhiana

Ludhiana
PUNJAB
141012
India 
Phone  09915515234  
Fax    
Email  gurdeep2005123@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mridul  
Designation  PG student 
Affiliation  Dayanand Medical College and Hospital, Ludhiana 
Address  Dept of Pediatrics, Dayanand Medical College and Hospital, Ludhiana

Ludhiana
PUNJAB
141012
India 
Phone  09915515234  
Fax    
Email  mkaileshwar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mridul  
Designation  PG student 
Affiliation  Dayanand Medical College and Hospital, Ludhiana 
Address  Dept of Pediatrics, Ward Number 209, second floor Dayanand Medical College and Hospital, Ludhiana

Ludhiana
PUNJAB
141012
India 
Phone  09915515234  
Fax    
Email  mkaileshwar@gmail.com  
 
Source of Monetary or Material Support  
Dayanand Medical college and Hospital, Tagore Nagar, Ludhiana, Punjab, India PIN 141012 
 
Primary Sponsor  
Name  Dayanand Medical college and Hospital Ludhiana 
Address  Dayanand Medical college and Hospital, Tagore nagar, Ludhiana, Punjab, India. Pin 141012 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gurdeep S Dhooria  Dayanand Medical College and Hospital, Ludhiana  Dept of Pediatrics, Dayanand Medical College and Hospital, Ludhiana
Ludhiana
PUNJAB 
09915515234

gurdeep2005123@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Research and Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: P220||Respiratory distress syndrome of newborn,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  28.00 Day(s)
Gender  Both 
Details  Premature babies
Respiratory distress syndrome
requiring CPAP 
 
ExclusionCriteria 
Details  Term neonates
Neonates requiring hospital stay of less than 24 hours
Neonates having congenital malformations like trachea oesophageal fistula, diaphragmatic hernia etc and complex congenital heart diseases.
Outborn neonates.
Neonates intubated immediately and put on mechanical ventilation in labour room.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To predict need for Surfactant therapy
 
Outcome will be assessed/estimated i.e. at baseline, 12 hours, 24 hours, 48 hours, and 72 hours after birth 
 
Secondary Outcome  
Outcome  TimePoints 
To predict the need for Mechanical ventilation in neonates using ROX index.
To predict the duration of hospital stay required .
To predict the duration of CPAP support required.
 
Outcome will be assessed/estimated i.e. at baseline, 12 hours, 24 hours, 48 hours, & 72 hours after birth 
 
Target Sample Size   Total Sample Size="220"
Sample Size from India="220" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [gurdeep2005123@gmail.com].

  6. For how long will this data be available start date provided 10-01-2026 and end date provided 10-01-2029?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary  

Respiratory Distress occurs among 4-7% of all neonates and is the most common reason for  30-40% of admissions in the Neonatal intensive care unit. It is more common among preterm (30%) and post term (21%) than term neonates.

 CPAP is a non-invasive type of respiratory support which can be delivered without endotracheal intubation though classical mechanical ventilators can also provide CPAP. It works by providing a continuous level of positive pressure to the airways which distends the lungs, overcomes collapse and improves ventilation.

 ROX index has not been validated in neonates with RDS earlier so it  will help to predict CPAP failure in neonates with RDS using simple and easily accessible clinical parameters like SpO2, FiO2, and Respiratory Rate to help minimise morbidity and mortality in preterm neonates by doing early intervention in the form of giving surfactant therapy and mechanical ventilation. Hence the need for the study.

 
Close